ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
US Tech 100
18,232.00
0.00%
Dow Jones
39,872.99
0.17%
Brent Oil
81.705
-0.90%
Bitcoin
69,809.55
-0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GRI Bio Inc (GRI) Quote

GRI Bio Inc

GRI Bio Inc (GRI)

Grainger Plc
Galore Resources Inc
0.4145
0.00
(0.00%)
Closed May 22 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.4145
Bid
0.405
Ask
0.42
Volume
-
0.00 Day's Range 0.00
0.375 52 Week Range 49.28
Previous Close
0.4145
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
246,163
Financial Volume
-
VWAP
-

GRI Latest News

More News

GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)

Data presented at the 14th International Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV® (nintedanib), a leading tyrosine kinase inhibitor with 2025...

19 hours ago
GlobeNewswire Inc.

GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

Compared to controls, mice treated with GRI-0621 showed improved fibrosis and immunopathology; Inhibition of type 1 invariant Natural Killer T (iNKT) cell activity led to a decrease in fibrosis...

May 20 2024
GlobeNewswire Inc.

GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase

Live webcast fireside chat on Tuesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company...

May 14 2024
GlobeNewswire Inc.

GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024...

May 13 2024
GlobeNewswire Inc.

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity

LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

April 29 2024
GlobeNewswire Inc.

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Live webcast on Wednesday, May 1st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...

April 25 2024
GlobeNewswire Inc.

GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent

Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation Continued advancement of an innovative pipeline of NKT cell...

April 16 2024
GlobeNewswire Inc.

GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference

LA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...

April 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0005-0.1204819277110.4150.47980.412269730.42078158CS
4-0.019-4.382929642450.43350.47980.3753798680.41938135CS
12-0.4355-51.23529411760.850.9150.3752461630.55148846CS
26-6.3727-93.89291607736.78728.17880.3756472912.22793253CS
52-41.8655-99.019631031242.2849.280.3753645253.42342952CS
156-91.9855-99.551406926492.493.310.3753415873.97081525CS
260-91.9855-99.551406926492.493.310.3753415873.97081525CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.352
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.34
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.85
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4874
(0.00%)
0
AACGATA Creativity Global
$ 0.9501
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.352
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.34
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.85
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4874
(0.00%)
0
AACGATA Creativity Global
$ 0.9501
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.352
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.34
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.85
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4874
(0.00%)
0
AACGATA Creativity Global
$ 0.9501
(0.00%)
0

GRI Discussion

View Posts
Monksdream Monksdream 3 months ago
GRI under $2
👍️0
littleharoldeh littleharoldeh 3 months ago
More like free falling
👍️0
tw0122 tw0122 3 months ago
Boom time
👍️0
Monksdream Monksdream 3 months ago
GRI new 52 week low
👍️0
Monksdream Monksdream 4 months ago
GRI new 52 week low
👍️0
Invest-in-America Invest-in-America 4 months ago
GRI: And THAR-she-goes!!!
👍️0
Awl416 Awl416 4 months ago
Wild
👍️0
IVANj IVANj 4 months ago
Boingggg
👍️0
TheFinalCD TheFinalCD 4 months ago
1-7 RS TOMORROW
👍️0
Renee Renee 4 months ago
GRI: effective Jan. 30,2024 a one for 7 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
KOGT KOGT 7 months ago
Go Gri!!!
👍️0
Monksdream Monksdream 8 months ago
GRI under $2
👍️0

Your Recent History

NASDAQ
GRI
GRI Bio
NASDAQ
PNNW
Pennichuck
BIT
P1U1G2
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved